PCH
IGMS

Polar Capital Holdings’s IGM Biosciences IGMS Stock Holding History

Polar Capital Holdings’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-106,436
Closed -$3.12K – 474
2021
Q4 		$3.12K Buy
106,436
+19,285
+22% +$958K 0.01% 279
2021
Q3 		$5.73K Buy
87,151
+66,007
+312% +$5.05M 0.02% 269
2021
Q2 		$1.76K Buy
+21,144
New +$1.57M 0.01% 308

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Polar Capital Holdings's IGMS Position: Q1 2022 in Review

Polar Capital Holdings sold out of IGM Biosciences (IGMS) in Q1 2022, closing a stake of 106,436 shares — an estimated $3.12K sold.

Polar Capital Holdings first reported a position in IGMS in Q2 2021 and held it in 3 quarters. The position peaked at $5.73K in Q3 2021. 93 funds tracked by Wall St. Rank hold IGMS as of Q1 2022.

  • Polar Capital Holdings reported no remaining IGM Biosciences position as of Q1 2022 after selling out during the quarter.
  • Polar Capital Holdings sold 106,436 IGM Biosciences shares in Q1 2022, an estimated $3.12K.
  • Polar Capital Holdings first reported a position in IGM Biosciences in Q2 2021 and held it in 3 quarters.
  • Polar Capital Holdings's IGM Biosciences position peaked at $5.73K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2022.

Based on Polar Capital Holdings's 13F filing for Q1 2022, filed 16 May 2022.